GlassScriptPhysician profile
James C Loden
NPI 1659330272
$39,873.17
in general payments reported to CMS, 2019-2025
25 companies · $8,999 in 2025
The $8,999 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,305 · 2020: $11K · 2021: $5,597 · 2022: $2,422 · 2023: $2,945 · 2024: $952 · 2025: $8,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,925 · Food and Beverage: $3,945 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,925.00 |
| Food and Beverage | $3,944.88 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $23,327.30 | 2019-2025 | Tecnis Iol, Veritas Vision System, Tecnis Iol |
| Lensar, INC. | $8,971.84 | 2019-2025 | Lensar Laser System |
| Bausch & Lomb Americas INC. | $2,657.11 | 2022-2024 | Clearvisc, Envista Mx60 Iol, Miebo |
| Omeros Corporation | $1,615.88 | 2019-2021 | |
| Glaukos Corporation | $750.31 | 2019-2025 | Idosetr, Idose |
| Biotissue Holdings INC. | $481.99 | 2022-2025 | |
| Abbvie INC. | $301.73 | 2022-2025 | |
| Allergan, INC. | $300.42 | 2020-2022 | |
| Alcon Vision LLC | $291.61 | 2019-2025 | Hydrus Microstent, Voyager Dslt, Wavelight Refractive Suite |
| New World Medical,INC. | $237.56 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $163.45 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $124.88 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $122.40 | 2022-2024 | |
| Carl Zeiss Meditec, INC. | $118.95 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $71.01 | 2019-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $68.16 | 2020 | |
| Rxsight INC | $55.66 | 2022-2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Light Adjustable Lens (Rxlal) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.36 | 2019 | |
| Shire North American Group INC | $43.67 | 2019 | |
| Eyepoint US, INC. | $41.70 | 2019-2021 | |
| Ivantis, INC | $21.96 | 2020 | |
| Ocular Therapeutix, INC. | $18.62 | 2023 | Dextenza |
| Sight Sciences, INC. | $18.02 | 2023 | Omni Surgical System |
| Oyster Point Pharma, INC. | $12.64 | 2022 | |
| Rayner Intraocular Lenses Limited | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Loden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.